Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Emilio D. Poggio, MD, is a Staff in the Department of Nephrology and Hypertension of the Glickman Urological and Kidney Institute at Cleveland Clinic. He also has joint appointments in the Transplant Center, Cleveland Clinic, and the Department of Immunology at Lerner Research Institute.
Dr. Poggio is board-certified in Nephrology and Hypertension. His clinical practice focuses on the care of subjects with kidney disease, specifically kidney and pancreas transplant candidates and recipients, and those with kidney disease following nonrenal organ transplantation.
Dr. Poggio has several major areas of clinical and translational research and has published and lectured about these topics: Assessment of kidney function (glomerular filtration rate) in health and in disease, Outcomes of living kidney donors and transplant recipients, Living donor kidney factors that relate to outcomes for transplant recipients and the development of tools to risk-stratify patients based on pre-transplantation data, Development of novel cellular immune-monitoring techniques in the setting of organ transplantation.
Dr. Poggio participates in several NIH-sponsored multi center studies aimed at various aspects of the field of kidney transplantation.
Kidney transplantation and pancreas transplantation, kidney disease in solid organ transplantation, evaluation of renal function, chronic kidney disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/19/2015, Dr. Poggio has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.